DIAGNOSTIC REPORT
MC-5897
PATIENT NAME : NEENU CHANDRAN REF. DOCTOR : SELF
ACCESSION NO : 4049XA000951 AGE/SEX : 26 Years Female
NEENU CHANDRAN PATIENT ID : NEENF1907970 DRAWN : 20/01/2024 12:30:10
THATTASERRY KIDARNGARA
CLIENT PATIENT ID: RECEIVED : 20/01/2024 12:31:24
ABHA NO : REPORTED :20/01/2024 16:16:35
Test Report Status Final Results Biological Reference Interval Units
SPECIALISED CHEMISTRY - HORMONE
HCG, SERUM
HCG <0.2 Non-Pregnant : < 5 mIU/mL
Pregnant(GAwise):
3wks : 5.8-71.2
4wks : 9.5-750
5wks : 217-7138
6wks : 158-31795
7wks : 3697- 163563
8wks : 32065- 149571
9wks : 63803- 151410
10wks : 46509- 186977
12wks : 27832- 210612
14wks : 13950- 62530
15wks : 12039- 70971
16wks : 9040- 56451
17wks : 8175- 55868
18wks : 8099-58176
Interpretation(s)
HCG, SERUM-HCG is a glycoprotein hormone that consists of 2 subunits (alpha and beta chains), which are associated to comprise the intact hormone.
HCG is produced in the placenta during pregnancy. In nonpregnant women, it can also be produced by tumors of the trophoblast, germ cell tumors with trophoblastic
components, and some nontrophoblastic tumors. Elevated hCG concentrations are also found in patients with other diseases such as tumors of the ovaries, bladder,
pancreas, stomach, lungs, and liver
The biological action of hCG serves to maintain the corpus luteum during pregnancy. Measurement of the hCG concentration permits the diagnosis of pregnancy as early as
1 week after conception. Elevated concentrations of hCG measured in the first trimester of pregnancy are observed in normal pregnancy, but may serve as an indication of
chorionic carcinoma, hydatiform mole, or multiple pregnancy.
Decreasing hCG concentrations indicate threatened or missed abortion, recent termination of pregnancy, ectopic pregnancy, or intrauterine death. Both normal and ectopic
pregnancies generally yield positive results of pregnancy tests. The comparison of quantitative hCG measurements with the results of transvaginal ultrasonography may aid
in the diagnosis of ectopic pregnancy.
**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession
Page 1 Of 1
DR.HARI SHANKAR, MBBS MD DR.SMITHA PAULSON,MD
(Reg No - TCMC:62092) (PATH),DPB
HEAD - Biochemistry & (Reg No - TCMC:35960)
Immunology LAB DIRECTOR & CONSULTANT
PATHOLOGIST View Details View Report
Patient Ref. No. 666000007562444